CD44 and chronic obstructive pulmonary disease: Susceptible smokers with COPD are likely to have a genetic background that favours an enhanced inflammatory response[38], and this may initiate the process by shedding macrophage CD44[36], hence limiting the efficiency of efferocytosis[7,8].